ALTEOGEN Inc.

South Korea · 25 Employees
ALTEOGEN Inc., Daejeon(fifth-largest metropolis)-based in South Korea, is a leading biopharmaceutical company with a leading edge pipeline of novel biologics such as next generation biobetters including long-acting therapeutic proteins, Antibody-Drug Conjugate (ADC) therapeutic antibodies and monoclonal antibody biosimilars. The company was founded in 2008 and listed in KOSDAQ stock market (KRX:196170). Our innovative NexP™ fusion technology is applied to various proteins and peptides to allow longer activities in human beings. Long-acting human Growth Hormone, long-acting exenatide (for diabetes) and long-acting Factor VIIa (for hemophilia) are developed with the NexP™ fusion technology. Our proprietary ADC technology, NexMab™ ADC technology is well suited for the targeted therapy for the cancer drugs with lower side effect and better efficacy. With this NexMab™ ADC technology, we are developing ADC therapeutics for breast/gastric cancer and ovarian cancer. Alteogen's mostly distinguished Hybrozyme™ technology to a human hyaluronidase, which has been widely used to improve the absorption of drug biologics delivered via subcutaneous injection. The novel human hyaluronidase based on Hybrozyme™ technology showed improved enzymatic activity and thermal stability. Based on long and rich experiences, Alteogen has quickly developed its own cell lines with high expression, efficient process (upstream and downstream), and optimized analysis methods for monoclonal antibody biosimilars including Herceptin preparing for the phase 3 trials upon completion of global phase 2 testing, SC formulation of Herceptin biosimilar as well as working on Eylea biosimilar.

概述

国家 South Korea
成立时间 2008
总部 62, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon 34054, KR
电话号码 +82 42-384-8780
网站 http://www.alteogen.com
LinkedIn http://www.linkedin.com/company/alteogen
Twitter
Facebook
员工数 25
行业 biotechnology,
简介 ALTEOGEN Inc., Daejeon(fifth-largest metropolis)-based in South Korea, is a leading biopharmaceutical company with a leading edge pipeline of novel biologics such as next generation biobetters including long-acting therapeutic proteins, Antibody-Drug Conjugate (ADC) therapeutic antibodies and monoclonal antibody biosimilars. The company was founded in 2008 and listed in KOSDAQ stock market (KRX:196170). Our innovative NexP™ fusion technology is applied to various proteins and peptides to allow longer activities in human beings. Long-acting human Growth Hormone, long-acting exenatide (for diabetes) and long-acting Factor VIIa (for hemophilia) are developed with the NexP™ fusion technology. Our proprietary ADC technology, NexMab™ ADC technology is well suited for the targeted therapy for the cancer drugs with lower side effect and better efficacy. With this NexMab™ ADC technology, we are developing ADC therapeutics for breast/gastric cancer and ovarian cancer. Alteogen's mostly distinguished Hybrozyme™ technology to a human hyaluronidase, which has been widely used to improve the absorption of drug biologics delivered via subcutaneous injection. The novel human hyaluronidase based on Hybrozyme™ technology showed improved enzymatic activity and thermal stability. Based on long and rich experiences, Alteogen has quickly developed its own cell lines with high expression, efficient process (upstream and downstream), and optimized analysis methods for monoclonal antibody biosimilars including Herceptin preparing for the phase 3 trials upon completion of global phase 2 testing, SC formulation of Herceptin biosimilar as well as working on Eylea biosimilar.

技术

Google Font API

Fonts

Google Maps

Other

Google Maps (Non Paid Users)

Other

Mobile Friendly

Other

Nginx

Load Balancers

WordPress.org

CMS

常见问题

ALTEOGEN Inc. 在哪里?

ALTEOGEN Inc. 的总部位于 62, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon 34054, KR

ALTEOGEN Inc. 的电话号码是多少?

ALTEOGEN Inc. 的电话号码是 +82 42-384-8780

ALTEOGEN Inc. 的官方网站是什么?

ALTEOGEN Inc. 的公司官方网站是 http://www.alteogen.com

ALTEOGEN Inc. 是做什么的?

ALTEOGEN Inc. 的业务有哪些?

biopharmaceuticals,biobetters,biosimilars

ALTEOGEN Inc. 的年收入是多少?

ALTEOGEN Inc. 的收入是 6000000美元

ALTEOGEN Inc. 有多少员工?

ALTEOGEN Inc. 有 25 名员工

ALTEOGEN Inc. 属于哪个行业?

ALTEOGEN Inc. 从事以下行业: biotechnology

ALTEOGEN Inc. 使用什么技术?

ALTEOGEN Inc. 使用的一些流行技术包括: Google Font API,Google Maps,Google Maps (Non Paid Users),Mobile Friendly,Nginx,WordPress.org

如何联系 ALTEOGEN Inc.?

ALTEOGEN Inc. 联系信息: 电话号码:+82 42-384-8780, 网站:http://www.alteogen.com, 邮箱:ema***@***.com

ALTEOGEN Inc. 的社交媒体链接是什么?

ALTEOGEN Inc. 领英:http://www.linkedin.com/company/alteogen,fackbook:,twitte:

ALTEOGEN Inc. 是一家上市公司吗?

不是

ALTEOGEN Inc. 的最后一轮融资是什么时候?

ALTEOGEN Inc.在2016-09-01T00:00:00.000+00:00结束了最后一轮融资,金额达9.1M$。

谁投资 ALTEOGEN Inc.?

ALTEOGEN Inc. 有 1 家投资者,包括 。

员工

Vivek Shenoy

Senior Vice President, Chief Business Officer

Jonghyun Son

Assistant Project Coordinator

Kyuwan Kim

Process Group Leader

Allan Kang

경영지원본부장

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google